These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7576567)

  • 1. HLA antigens in ulcerative colitis and primary sclerosing cholangitis.
    Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA
    APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of primary sclerosing cholangitis with HLA-B8.
    Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S
    Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
    Chapman RW; Cottone M; Selby WS; Shepherd HA; Sherlock S; Jewell DP
    Gut; 1986 Jan; 27(1):86-91. PubMed ID: 3485067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.
    Habior A; Rawa T; Orłowska J; Sankowska M; Lewartowska A; Tilszer A; Pawlak J; Krawczyk M; Butruk E
    Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):787-91. PubMed ID: 12169991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.
    Zetterquist H; Broomé U; Einarsson K; Olerup O
    Gut; 1992 Jul; 33(7):942-6. PubMed ID: 1644334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS; Lo S; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of primary sclerosing cholangitis with HLA-DRw52a.
    Prochazka EJ; Terasaki PI; Park MS; Goldstein LI; Busuttil RW
    N Engl J Med; 1990 Jun; 322(26):1842-4. PubMed ID: 2348837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
    Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
    Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
    Wiencke K; Spurkland A; Schrumpf E; Boberg KM
    Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis.
    Broomé U; Hultcrantz R; Lefvert AK; Yi Q
    Dis Colon Rectum; 1998 Dec; 41(12):1543-9. PubMed ID: 9860336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
    Mehal WZ; Lo SK; Chapman RW; Fleming KA
    J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic parameters in pericholangitis and primary sclerosing cholangitis with and without ulcerative colitis].
    Hopf U; Riecken EO; Zeitz M; Eckhardt R; Lobeck H; Malchus R; Möller B
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1515-21. PubMed ID: 6617507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerative colitis and persistent liver dysfunction.
    Shepherd HA; Selby WS; Chapman RW; Nolan D; Barbatis C; McGee JO; Jewell DP
    Q J Med; 1983; 52(208):503-13. PubMed ID: 6657913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immune factors in the pathogenesis of primary sclerosing cholangitis.
    Chapman RW
    Semin Liver Dis; 1991 Feb; 11(1):1-4. PubMed ID: 2047883
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
    Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
    Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.